New immunotherapy triple strategy for AML.
Senior
Kathryn
K
D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007951:Leukemia, Myeloid / Q000628:therapy*; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000276:immunology
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor